NCCN Guidelines for HR+ HER2 Metastatic Breast Cancer
2 विचारों
administrator
07/03/23
Debu Tripathy, MD, and Hatem Soliman, MD, reflect on the NCCN guideline criteria and patient factors that play into decision making for frontline therapy in hormone receptor–positive metastatic breast cancer.
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली